Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Erythromycin
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01FA
- Strength
- 4 %
- Dosage form
- Topical solution
- Pack
- 60ml
- Registration no.
- 065244
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Gloss Liquid (Erythromycin) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Erythromycin is right for you and the dose.
- Acne: Used instead of a tetracycline if it cannot be taken or causes side effects
- Acute bronchitis: alternative when an antibiotic is needed and the first choice is unsuitable, for example in penicillin allergy
- Cholera: first choice antibiotic for children and pregnant women, and an alternative for adults
- Conjunctivitis (pink eye): For bacterial pink eye when your doctor thinks treatment is needed. Chloramphenicol drops are a common first choice in UK guidance. Fluoroquinolone drops are kept for more severe infection and for contact lens wearers. Ointment is sometimes used at night. They do not help viral or allergic pink eye
- Eczema (atopic dermatitis): only when an infection is spreading, severe or the person is unwell
- Impetigo: Used instead of a penicillin if you are allergic to penicillin. Erythromycin is the preferred macrolide in pregnancy if one is needed
- Middle ear infection (otitis media): alternative for people allergic to penicillin
- Sinusitis: not needed for most people
- Sore throat (pharyngitis and tonsillitis): an option for people allergic to penicillin
About Gloss Liquid 4 % topical solution
Gloss Liquid 4 % topical solution contains Erythromycin 4 %. It is registered with DRAP by Werrick Pharmaceuticals (registration no. 065244). Its official price is PKR 63.18 for a pack of 60ml. The price changed from PKR 60.20 to PKR 63.18 on 17 August 2026. No other brand of Erythromycin 4 % in this form is listed in Pakistan.
Other brands of Erythromycin 4 % solution in Pakistan
No other brand of Erythromycin 4 % solution is listed in Pakistan. See all strengths and forms of Erythromycin →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Gloss Liquid, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Werrick Pharmaceuticals, Islamabad
- DRAP registration
- 065244
- Phone
- +92 51 4441022
Contact details as published by the company, last checked on 28 October 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 60.20 to 63.18 (+5.0%) between 18 Aug 2025 and 17 Aug 2026 · 2 official price records · pack 60ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Gloss Liquid 4 %, 60ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/gloss-liquid-4-065244-60ml-werrick-pharmaceuticals/ (accessed 11 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 63.18 | 2026-08-17 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 60.20 | 2025-08-18 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 065244Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.